ELI LILLY & Co

LLY 10-K · Q4 2025
API behind this page

LLY Q4 2025 request

Playground key active
Request URL /api/financials?ticker=LLY&year=2025&quarter=4
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q4 2025 Q4 2024 YoY
Revenue 19,292 13,533.1 +42.6%
Show Product Lines breakouts
Cardiometabolic Health · Non Us 4,435.5 2,579.4 +72.0%
Cardiometabolic Health · US 10,056.7 6,527 +54.1%
Collaboration and Other Revenue [Member] 991.7 1,508.1 -34.2%
Immunology · Non Us 629.4 524 +20.1%
Immunology · US 911.6 767 +18.9%
Jardiance 768.6 1,198.5 -35.9%
Jardiance · Non Us 301.8 733.6 -58.9%
Jardiance · US 465.8 464.9 +0.2%
Mounjaro · Non Us 3,267 898.7 +263.5%
Mounjaro · US 4,143.2 2,631.3 +57.5%
Neuroscience · Non Us 139 170 -18.2%
Neuroscience · US 320.2 223.6 +43.2%
Oncology · Non Us 1,095.4 1,084.4 +1.0%
Oncology · US 1,511.9 1,468.1 +3.0%
Other cardiometabolic health · Non Us 492.4 496.4 -0.8%
Other cardiometabolic health · US 524.5 723.2 -27.5%
Other immunology · Non Us 301.6 237.7 +26.9%
Other immunology · US 187.3 101.7 +84.2%
Other oncology · Non Us 487.8 571.5 -14.6%
Other oncology · US 514.9 425.5 +21.0%
Other · Non Us 114.4 144.6 -20.9%
Other · US 77 46 +67.4%
Product 18,300.3 12,025 +52.2%
Taltz · Non Us 327.8 286.3 +14.5%
Taltz · US 724.3 665.3 +8.9%
Trulicity · Non Us 344 450.7 -23.7%
Trulicity · US 692.8 800 -13.4%
Verzenio · Non Us 607.6 512.9 +18.5%
Verzenio · US 997 1,042.6 -4.4%
Zepbound · US 4,230.4 1,907.6 +121.8%
Show Business Segments breakouts
Reportable Segment 19,292 13,533.1 +42.6%
Show Geography breakouts
CN 473.2 428.8 +10.4%
Europe 3,096.8 2,448.3 +26.5%
JP 654.8 559.3 +17.1%
Non Us 6,414.6 4,501.3 +42.5%
Rest of world 2,189.8 1,063.9 +105.8%
US 12,877.4 9,031.8 +42.6%
Show — breakouts
Revenue -33,358.9 -20,114.6 -65.8%
Cost of Revenue 3,371.7 2,403.5 +40.3%
Show Business Segments breakouts
Reportable Segment 3,371.7 2,403.5 +40.3%
Research And Development Expense Excluding Acquired In Process Cost 3,801.5 3,022.9 +25.8%
Show Product Lines breakouts
Early-stage · Reportable Segment 1,485.4 1,044.4 +42.2%
Late-stage · Reportable Segment 2,316.1 1,978.5 +17.1%
Selling, General & Administrative 3,131.4 2,424.7 +29.1%
Show Business Segments breakouts
Reportable Segment 3,131.4 2,424.7 +29.1%
Research And Development Asset Acquired Other Than Through Business Combination Written Off 528.8 188.8 +180.1%
Show Business Segments breakouts
Reportable Segment 528.8 188.8 +180.1%
Restructuring Settlement And Impairment Provisions 84.1 344.4 -75.6%
Non-Operating Income (Expense) 108.3 110.5 -2.0%
Cost Of Sales Operating Expenses And Other Net 11,025.8 8,494.8 +29.8%
Income Before Taxes 8,266.2 5,038.3 +64.1%
Income Tax Expense (Benefit) 1,628.5 628.5 +159.1%
Net Income 6,637.7 4,409.8 +50.5%
Show Business Segments breakouts
Reportable Segment 6,637.7 4,409.8 +50.5%
EPS (Basic) 7.4 4.9 +51.0%
EPS (Diluted) 7.39 4.88 +51.4%
Wtd Avg Shares (Basic) -0.5 -0.3 -66.7%
Wtd Avg Shares (Diluted) -0.4 -0.3 -33.3%
Interest Expense 222.6 225.1 -1.1%
Net Income (Q) — — —
Show Equity Components breakouts
Retained Earnings 6,637.7 4,409.8 +50.5%
Comprehensive Income 6,964.1 4,362.6 +59.6%
Other Comprehensive Income 326.4 -47.2 +791.5%
Show Equity Components breakouts
Accumulated Other Comprehensive Income 326.4 -47.2 +791.5%

Balance Sheet

Balance Sheet
Metric Q4 2025 Q4 2024 YoY
Current Assets
Cash & Cash Equivalents 7,268 3,268 +122.4%
Accounts Receivable 17,760 11,006 +61.4%
Other Receivables Net Current 2,395 2,270 +5.5%
Inventory 13,744 7,589 +81.1%
Prepaid Expense Current 14,315 8,341 +71.6%
Other Assets Current 147 266 -44.7%
Total Current Assets 55,629 32,740 +69.9%
Non-Current Assets
Long Term Investments 2,802 3,216 -12.9%
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure 2,802 3,216 -12.9%
Goodwill 5,898 5,770 +2.2%
Intangible Assets Net Excluding Goodwill 6,521 6,166 +5.8%
Deferred Tax Assets 9,959 8,001 +24.5%
Property, Plant & Equipment 24,675 17,102 +44.3%
Other Non-Current Assets 6,992 5,720 +22.2%
Total Assets 112,476 78,715 +42.9%
Operating Lease Right-of-Use Assets 1,260 1,050 +20.0%
Intangible Assets (Q) — — —
Show Finite Lived Intangible Assets By Major Class breakouts
Developed Technology Rights 4,952 5,269 -6.0%
Current Liabilities
Debt Current 1,635 5,117 -68.0%
Accounts Payable 5,379 3,229 +66.6%
Employee Related Liabilities Current 2,375 2,094 +13.4%
Sales Rebates And Discounts 17,382 11,539 +50.6%
Other Liabilities Current 8,457 6,397 +32.2%
Total Current Liabilities 35,228 28,376 +24.1%
Non-Current Liabilities
Long-Term Debt 40,868 28,527 +43.3%
Accrued Income Taxes Noncurrent 5,875 4,061 +44.7%
Other Non-Current Liabilities 3,970 3,479 +14.1%
Liabilities Noncurrent 50,713 36,067 +40.6%
Long-Term Debt (Q) — — —
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level2 · Carrying Reported Amount Fair Value Disclosure 42,503 29,307 +45.0%
Fair Value Inputs Level2 · Estimate Of Fair Value Fair Value Disclosure 39,799 26,249 +51.6%
Show Debt Instrument breakouts
August 2024 Issuance Date Debt 5,000 — —
August 2025 Issuance Date Debt 6,750 — —
February 2023 Issuance Date Debt 4,000 — —
February 2024 Issuance Date Debt 6,500 — —
February 2025 Issuance Date Debt 6,500 — —
Show Long-Term Debt Type breakouts
Floating-Rate Notes 750 — —
Operating Lease Liabilities 1,140 971 +17.4%
Stockholders' Equity
Common Stock 590 592 -0.3%
Additional Paid In Capital Common Stock 7,346 7,439 -1.3%
Retained Earnings 24,470 13,545 +80.7%
Common Stock Shares Held In Employee Trust -3,013 -3,013 0.0%
Accumulated Other Comprehensive Income -2,880 -4,322 +33.4%
Other Additional Capital 22 31 -29.0%
Total Stockholders' Equity 26,535 14,272 +85.9%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -1,987 -2,179 +8.8%
Accumulated Other Comprehensive Income -2,880 -4,322 +33.4%
Accumulated Translation Adjustment -1,149 -2,390 +51.9%
Additional Paid In Capital 7,346 7,439 -1.3%
Common Stock 590 592 -0.3%
Other 255 246 +3.7%
Retained Earnings 24,470 13,545 +80.7%
Trust For Benefit Of Employees -3,013 -3,013 0.0%
Total Liabilities & Equity 112,476 78,715 +42.9%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q4 2025 YTD Q4 2024 YoY
Operating Activities
Depreciation & Amortization 585.7 485.2 +20.7%
Increase Decrease In Deferred Income Taxes -748.1 -966.6 +22.6%
Stock-Based Compensation 136.1 142.3 -4.4%
Other Operating Activities Cash Flow Statement -61.5 662.3 -109.3%
Net Cash from Operations 3,224.6 2,473.9 +30.3%
Investing Activities
Payments To Acquire Other Property Plant And Equipment -2,546.7 -1,496.2 -70.2%
Proceeds From Sale And Maturity Of Other Investments 132 56 +135.7%
Payments To Acquire Other Investments -127 -151.9 +16.4%
Payments To Acquire In Process Research And Development -423.7 -251.4 -68.5%
Other Payments To Acquire Businesses -111.6 -0.3 -37100.0%
Other Investing Activities 56.8 -678.2 +108.4%
Net Cash from Investing -2,802.2 -1,921 -45.9%
Financing Activities
Payments Of Dividends -1,345.5 -1,167.9 -15.2%
Proceeds From Repayments Of Short Term Debt -0.4 3,042.1 -100.0%
Proceeds From Issuance Of Long Term Debt -0.2 -0.1 -100.0%
Repayments Of Long Term Debt 0.1 0.2 -50.0%
Share Repurchases -1,507.7 -2,053.9 +26.6%
Proceeds From Payments For Other Financing Activities -25.1 -45.9 +45.3%
Net Cash from Financing -2,878.8 -225.5 -1176.6%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -67.1 -428.8 +84.4%
Net Change in Cash -2,523.5 -101.4 -2388.7%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 7,268 3,268 +122.4%

Values in millions USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key